Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

Go back to Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
(NASDAQ: AVIR) Delayed: 4.99 +0.08 (1.63%)
Previous Close $4.91    52 Week High $2.00 
Open $4.96    52 Week Low $1.15 
Day High $5.00    P/E N/A 
Day Low $4.75    EPS $0.00 
Volume 306,539